Glucocorticoid receptor-mediated post-ceramide inhibition of the interleukin-1 beta-dependent induction of ovarian prostaglandin endoperoxide synthase-2 in rats
M. Irahara et al., Glucocorticoid receptor-mediated post-ceramide inhibition of the interleukin-1 beta-dependent induction of ovarian prostaglandin endoperoxide synthase-2 in rats, BIOL REPROD, 60(4), 1999, pp. 946-953
Ovulation may constitute a cyclic, inflammatory-like process, wherein inter
leukin (IL)-1 induction and increased biosynthesis of prostanoids may featu
re prominently. In excess, glucocorticoids, potent anti-inflammatory agents
, may exert an antiovulatory effect. This paper addresses the possibility t
hat the antiovulatory action of glucocorticoids may be partly due to interf
erence with ovarian prostanoid biosynthesis. Specifically, we examined the
effect of treatment with dexamethasone, a synthetic glucocorticoid, on the
IL-l-induced expression and activity of ovarian prostaglandin endoperoxide
synthase (PCS)-2, the inducible variety of the rate-limiting enzyme in the
prostaglandin cascade. Treatment of cultured whole ovarian dispersates from
immature rats with dexamethasone for 48 h produced a significant decrease
(98.9% inhibition) in the Ill-supported expression of PGS-2 transcripts. Co
mparably marked inhibition was also noted for the corresponding immunoreact
ive protein. The dexamethasone effect was not limited to the Il-1-mediated
induction of PGS-2 transcripts, comparable suppression being noted for the
IL-1-mediated up-regulation of ovarian transcripts corresponding to IL-1 be
ta, the IL-1 receptor antagonist, and the type I IL-1 receptor. The order o
f potency of the glucocorticoids studied was dexamethasone > prednisolone =
cortisol. Dexamethasone proved equally effective in suppressing the induct
ion of PGS-2 transcripts by congeners of the sphingomyelin-ceramide cycle (
e.g., C-2 ceramide, sphingomyelinase, and sphingosine), The dexamethasone e
ffect proved glucocorticoid-specific, as synthetic agonists representative
of the progestin (R-5020), androgen (R-1881), and estrogen (diethylstilbest
rol) steroid series proved to be without effect. Cotreatment with RU-486 re
sulted in reversal of the ability of dexamethasone to suppress PGS-2 activi
ty or expression. Taken together, these observations suggest that dexametha
sone is capable of glucocorticoid receptor-mediated/post-ceramide suppressi
on of IL-1-supported ovarian PGS-2 transcript protein, and activity, These
findings are compatible with the view that the chronic anovulatory state as
sociated with adrenal hyperactivity or glucocorticoid excess may be due in
part to inhibition of ovarian prostaglandin biosynthesis.